18 Members•4,119 Posts

Pharma & Biotech

Grey Matters launches US brain PET clinics for Alzheimer’s diagnostics

May 20, 2026

Stephen Gunnion

Novo Nordisk cautiously optimistic on key GLP-1 obesity study, says Deutsche Bank

May 20, 2026

Ian Lyall

Grey Matters Health rebrands around a new brain health vision

May 20, 2026

Angela Harmantas

Grey Matters Health to supply PET scans for upcoming Alzheimer's research trial

May 20, 2026

Emily Jarvie

hVIVO to host capital markets day as it pitches broader clinical development role

May 20, 2026

Ian Lyall

Tiziana reports encouraging Expanded Access data for Foralumab in MS patients

May 19, 2026

Steve Darling

Inside Biotech: Island Pharmaceuticals pushes deeper into US biodefence as Ebola fears spark interest

May 19, 2026

Lisa Uhlman

Tiziana Life Sciences price target boosted on foralumab update

May 19, 2026

Emily Jarvie

OKYO Pharma Strengthens Scientific Advisory Board With Marta Sacchetti Appointment

May 19, 2026

Steve Darling

BCAL expands early cancer detection access to 97% of Australian GPs

May 19, 2026

Jonathan Jackson

Cavendish sees IXICO forecasts as conservative after order book hits five-year high

May 19, 2026

Ian Lyall

OKYO Pharma adds ophthalmology specialist Marta Sacchetti to Scientific Advisory Board

May 19, 2026

Emily Jarvie

Tiziana Life Sciences reports encouraging one-year data for intranasal foralumab in progressive MS

May 19, 2026

Angela Harmantas

Immunic appoints Biogen, Cubist veteran Mike Bonney as board chair ahead of key MS trial readout

May 19, 2026

Angela Harmantas

BioHarvest Sciences and Tate & Lyle expand sweetener development program

May 19, 2026

Emily Jarvie

BioVie completes final patient visit in Parkinson's drug trial

May 19, 2026

Angela Harmantas

Coiled Therapeutics begins trading on US OTCQB market to broaden investor base

May 19, 2026

Ian Lyall

EMV Capital grows assets under management to £112.5m as venture platform scales

May 19, 2026

Ian Lyall

IXICO reports strong H1 revenue growth as Alzheimer’s trial demand accelerates

May 19, 2026

Stephen Gunnion

IXICO targets 15% revenue growth as order book swells and strategy takes shape

May 19, 2026

Ian Lyall

Powered by RoundtableAn AI/DeFi-powered Enterprise Media Operating System. Learn more at Roundtable.io.© Roundtable 2026. By using this site you agree to the Terms of Use and Privacy Policy